<DOC>
	<DOC>NCT00326053</DOC>
	<brief_summary>The purpose of this study is to compare the Symbicort® Turbuhaler® to both Pulmicort® Turbuhaler® and Bricanyl® Turbuhaler® for the treatment of asthma after discharge from the emergency room</brief_summary>
	<brief_title>Prevention of Asthma Relapse After Discharge From Emergency</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>18 65 years of age Presenting at a study emergency department with an asthma exacerbation Admission to hospital Patients receiving more than 2000 µg/day of beclomethasone equivalent inhaled corticosteroids (1000 µg/day fluticasone or 1600 µg/day budesonide)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Asthma Reoccurrence</keyword>
	<keyword>Acute Asthma</keyword>
	<keyword>Patient Discharge</keyword>
	<keyword>Emergency Service, Hospital</keyword>
	<keyword>Asthma Exacerbation</keyword>
	<keyword>Asthma Relapse</keyword>
</DOC>